Loading...
Selection of the First (99m)Tc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation—Preclinical Assessment of Two Optimized Candidates
Recently, radiolabelled antagonists targeting somatostatin receptors subtype 2 (SST2) in neuroendocrine neoplasms demonstrated certain superior properties over agonists. Within the ERA-PerMED project “TECANT” two (99m)Tc-Tetramine (N4)-derivatized SST2 antagonists (TECANT-1 and TECANT-2) were studie...
Na minha lista:
| Udgivet i: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7824897/ https://ncbi.nlm.nih.gov/pubmed/33379299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14010019 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|